Headache in children and adolescents
https://doi.org/10.21518/2079-701X-2014-1-40-44
Abstract
Headache (H) is one of the most frequent complaints in schoolchildren. The frequency of H in child and adolescent population is growing, making H both a general health and social-economic challenge. Primary H, as H in general, affects the life quality of the younger generation, limits the child's activity, impairs social contacts, often requires use of analgesics and other drugs with possibility of developing an addiction, increasing the dose and manifestations of toxic effects [1]. Pediatrician's role when dealing with such patients is to determine whether H is primary or secondary, concomitant with other disorders (injuries, sinusitis, eye disease, etc.), in order to better target and time consultations, patient management tactics and the volume of interaction with the family [2-4].
About the Authors
V. M. Delyagin
Federal Research and Clinical Centre of Pediatric Hematology, Oncology and Immunology, Russian Ministry of Health, department of outpatient pediatrics, Pirogov Russian National Research Medical University, Moscow
Russian Federation
Russian Federation
A. U. Urazbagambetov
Federal Research and Clinical Centre of Pediatric Hematology, Oncology and Immunology, Russian Ministry of Health, department of outpatient pediatrics, Pirogov Russian National Research Medical University, Moscow
Russian Federation
Russian Federation
References
1. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 2000. 55. 754-762.
2. Mazzotta G, Gallai B, Mattioni A. et al. Cost assessment of headache in childhood and adolescence: preliminary data. Journal Headache Pain, 2005. 6, Suppl. 4. 281-283.
3. Talarska D. Quality of life in healthy children and in children with tension headaches - a comparative analysis. Rocz. Akad. Med. Bialymst., 2005. 50, Suppl 1. 126-128.
4. Swaiman K, Ashwal St, Ferriero DM, Ferriero D. Headaches in Infants and Children. / Pediatric Neurology: Principles and Practice, Fifth Edition, Elsevier Inc., London, 2012, Chapter 63, 880-899.
5. Будчанова Н.Ю. Головные боли у школьников (эпидемиология, клиника, анализ агравирующих и социальных факторов). Автореферат дисс. км.н. М, 2008. 29.
6. Gessel H, Gassmann Je, Kroener-Herwig B. Children in Pain: Recurrent Back Pain, Abdominal Pain, and Headache in Children and Adolescents in a Four-Year-Period. Journal of Pediatrics, 2011. 158. . 977-983.
7. Талицкая О.Е., Шварков С.Б. Цефалгический синдром при вегетативной дисфункции у детей Клинические проявления мигрени у детей. Журнал неврологии и психиатрии им. С.С. Корсакова, 1999. 1. 11-14.
8. Кваскова И.В., Шварков С.Б. Клинические проявления мигрени у детей. Журнал неврологии и психиатрии им. С.С. Корсакова, 1999. 1. 15-17.
9. Pro S, Tarantino S, Capuano A, Vigevano F, Valeriani M. Primary headache pathophysiology in children: The contribution of clinical neurophysiology Clinical Neurophysiology, 2014. 125. 6-12.
10. Горюнова А.В., Пак Л.А. Современная классификация, эпидемиология и патогенез головной боли у детей. Российский педиатрический журнал, 2006. 4. 33-36.
11. Кешишян Е.С., Казанцева Л.З., Николаева Е.А., Тозлиян Е.В. Использование препарата Элькар (L-карнитин) в педиатрии. Terra Medica, 2001. 4. 42-43.
12. Неудахин Е.В., Дьяконова О.В., Румянцев А.Л. Основные эффекты элькара и опыт его применения у детей. Практика педиатра, 2007. 3. 22-24.
13. Zhang R, Zhang H, Zhang Z et al. Neuroprotective effect of pre-treatment with L-carnitine and acetyl-L-carnitine on ischemic injury in vitro and in vivo. Int. J. Mol. Sci, 2013. 13. 2078-2090.
14. Рычкова Т.И., Остроухова И.П., Яковлев А.А., Акулова Л.К. и соавт. Коррекция функций сердечно-сосудистой системы препаратом L-карнитина у детей и подростков с сочетанной патологией. Лечащий врач, 2010. 8. 2-4.
15. Брин И.Л. Элькар в педиатрии. Научный обзор. НЦЗД РАМН. М., 2004. 35.
16. Гнетнева Е.С. Возможность коррекции нарушений адаптации у детей с помощью энерготропной терапии. Материалы XV конгресса «Человек и лекарство». М., 2008. 609.
17. Mitchel N, Angelo L, Neinstein L Adolescents health. Lippincott Williams & Wilkins, Philadelphia, 2003. 120.
18. Hershey A, Powers S, Vockell A, Lecates S, Ellinor P, Segers A et alCoenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache, 2007. 47. 73 Hershey 80.
Review
For citations:
Delyagin VM, Urazbagambetov AU. Headache in children and adolescents. Meditsinskiy sovet = Medical Council. 2014;(1):40-44. (In Russ.) https://doi.org/10.21518/2079-701X-2014-1-40-44
Views:
546
Email this article 